DVAX
DYNAVAX TECHNOLOGIES CORPCompany Information
- Company Name
- DYNAVAX TECHNOLOGIES CORP
- CIK
- CIK0001029142
- Category
- Large accelerated filer
- Ticker: Exchange
- DVAX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- DVAX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-22
- Last sale
- 2026-01-15
- Shares purchased (TTM)
- 3,800
- Shares sold (TTM)
- 1,170,927
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 109,456,867
- Shares outstanding
- 117,307,000
- Ownership
- 93.31%
Earnings Market Reaction
- Filing date
- 2025-11-05
- Price on filing date
- —
- 1-month reaction
- 10.39%
- 3-month reaction
- 50.58%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 160 | 99 | 52 | 96 | 119 | 113 | 132 | 150 | 155 | 227 | 174 | 202 | ||||||
| Series B Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Available For Sale Securities Debt Securities Current | 488 | 515 | 610 | 618 | 645 | 623 | 592 | 592 | 566 | 455 | 478 | 422 | ||||||
| Accounts And Other Receivables Net Current | 72 | 71 | 55 | 45 | 73 | 62 | 44 | 41 | 46 | 43 | 102 | 145 | ||||||
| Other Receivables | 1 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 1 | 2 | 3 | 2 | ||||||
| Inventory Net | 73 | 76 | 74 | 70 | 62 | 62 | 62 | 53 | 49 | 53 | 58 | 59 | ||||||
| Prepaid Expense And Other Assets Current | 20 | 23 | 24 | 18 | 25 | 21 | 20 | 19 | 19 | 17 | 16 | 86 | ||||||
| Assets Current | 814 | 786 | 816 | 849 | 926 | 882 | 851 | 859 | 836 | 797 | 830 | 917 | ||||||
| Property Plant And Equipment Net | 46 | 46 | 43 | 39 | 37 | 36 | 36 | 37 | 36 | 37 | 38 | 38 | ||||||
| Operating Lease Right Of Use Asset | 20 | 20 | 21 | 22 | 22 | 23 | 23 | 24 | 25 | 25 | 25 | 26 | ||||||
| Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 64 | 65 | 64 | 75 | 74 | 74 | 73 | 74 | 74 | 74 | 74 | 4 | ||||||
| Assets | 947 | 918 | 946 | 986 | 1,062 | 1,016 | 987 | 997 | 973 | 936 | 970 | 986 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 3 | 4 | 9 | 7 | 5 | 2 | 5 | 3 | 3 | 7 | 3 | ||||||
| Accrued Liabilities Current | 52 | 66 | 54 | 61 | 54 | 48 | 46 | 49 | 43 | 34 | 28 | 31 | ||||||
| Convertible Notes Payable Current | 40 | 40 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | ||||||
| Liabilities Current | 107 | 118 | 68 | 79 | 70 | 62 | 56 | 62 | 54 | 45 | 92 | 150 | ||||||
| Convertible Notes Payable | - | - | 261 | 224 | 224 | 223 | 223 | 223 | 222 | 222 | 222 | 222 | ||||||
| Convertible Long Term Notes Payable | 221 | 221 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 24 | 25 | 26 | 26 | 27 | 27 | 29 | 30 | 31 | 32 | 32 | 33 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities | 412 | 424 | 415 | 389 | 381 | 373 | 368 | 375 | 368 | 359 | 406 | 405 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,487 | 1,474 | 1,533 | 1,505 | 1,591 | 1,576 | 1,562 | 1,555 | 1,542 | 1,528 | 1,516 | 1,511 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 1 | -3 | -5 | 1 | -5 | -4 | -2 | -6 | -5 | -4 | -5 | ||||||
| Retained Earnings Accumulated Deficit | -954 | -981 | -999 | -903 | -910 | -928 | -939 | -931 | -931 | -945 | -949 | -924 | ||||||
| Stockholders Equity | 534 | 494 | 531 | 597 | 681 | 643 | 618 | 622 | 605 | 577 | 564 | 581 | ||||||
| Liabilities And Stockholders Equity | 947 | 918 | 946 | 986 | 1,062 | 1,016 | 987 | 997 | 973 | 936 | 970 | 986 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 0 | ||||||
| Contract With Customer Asset Accumulated Allowance For Credit Loss Noncurrent | 11 | 11 | 11 | - | - | - | - | - | - | - | - | - | ||||||
| Debt Instrument Unamortized Discount | - | - | 5 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Debt Instrument Unamortized Discount Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Debt Instrument Unamortized Discount Noncurrent | 4 | 4 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 278 | 278 | 278 | 278 | 278 | 278 | 278 | 278 | 278 | 278 | 278 | 278 | ||||||
| Shares Outstanding | 117 | 117 | 124 | 125 | 131 | 131 | 131 | 130 | 129 | 129 | 128 | 128 | ||||||
| Common Stock Shares Issued | 117 | 117 | 124 | 125 | 131 | 131 | - | 130 | 129 | 129 | 128 | 128 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDYNAVAX TECHNOLOGIES CORP (DVAX) — SEC Financial Statements & Analysis
DYNAVAX TECHNOLOGIES CORP (DVAX) is a pharmaceutical preparations company, incorporated in DE. DYNAVAX TECHNOLOGIES CORP trades on Nasdaq as: DVAX. DYNAVAX TECHNOLOGIES CORP (DVAX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-05. Based on that filing, On profitability, DYNAVAX TECHNOLOGIES CORP posts a gross margin of 83.17%, an operating margin of 3.16%, a net margin of -13.13%, a Return on Equity (ROE) of -7.14%, a Return on Assets (ROA) of -4.32%, and a Return on Invested Capital (ROIC) of 1.73%. Per share, it reports EPS of $-0.37, diluted EPS of $-0.32, free cash flow per share of $0.69, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 26.73% year-over-year, net income growth of -311.94% year-over-year, and EPS growth of -336.92% year-over-year. On the balance sheet, it maintains a current ratio of 7.62x, a quick ratio of 6.75x, working capital of $707.49M, a debt-to-equity ratio of 0.77x, a debt ratio of 0.44, an interest coverage ratio of 1.56x, free cash flow of $80.54M (TTM), and net debt of $100.49M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.37
- ROE TTM
- -7.14%
- ROA TTM
- -4.32%
- Debt To Equity
- 0.77x
- Free Cash Flow TTM
- $80.54M
- Net Revenue TTM Growth 1Y
- 26.73%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DYNAVAX TECHNOLOGIES CORP in?
DYNAVAX TECHNOLOGIES CORP (DVAX) operates in the Pharmaceutical Preparations industry.
What exchange does DVAX trade on?
DYNAVAX TECHNOLOGIES CORP (DVAX) trades on the Nasdaq.
Where is DYNAVAX TECHNOLOGIES CORP incorporated?
DYNAVAX TECHNOLOGIES CORP is incorporated in DE.
When was DYNAVAX TECHNOLOGIES CORP (DVAX)'s most recent SEC filing?
DYNAVAX TECHNOLOGIES CORP (DVAX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-05.
What is DVAX's EPS (earnings per share)?
DYNAVAX TECHNOLOGIES CORP (DVAX)'s trailing twelve month EPS is $-0.37 as of 2025-09-30.
What is DVAX's ROE (return on equity)?
DYNAVAX TECHNOLOGIES CORP (DVAX)'s trailing twelve month Return on Equity (ROE) is -7.14% as of 2025-09-30.
What is DVAX's ROA (return on assets)?
DYNAVAX TECHNOLOGIES CORP (DVAX)'s trailing twelve month Return on Assets (ROA) is -4.32% as of 2025-09-30.
What is DVAX's ROIC (return on invested capital)?
DYNAVAX TECHNOLOGIES CORP (DVAX)'s trailing twelve month Return on Invested Capital (ROIC) is 1.73% as of 2025-09-30.